Richard J. Willke - Publications, H-index & Citations

Richard J. Willke

scintegral health economics llc

35H指数

150论文数

6.4K被引数

收录论文 44

发表时间

Finding the right tool for the specific task: navigating RWE tools and checklists 为特定任务找到合适的工具：导航RWE工具和检查清单

Future Oncology

IF2.6

2025-09-01

OAAI

Richard Willke; Paul Cottu; Andrew Briggs; Uwe Siebert; Connie Chen; Beata Korytowsky; Julien Heidt; Meghan Renfrow; Kate Lovett; Adam Brufsky

The Value of the Quality-Adjusted Life Years

VALUE IN HEALTH

IF6

2024-05-01

PREAI

Willke, Richard J.; Pizzi, Laura T.; Rand, Leah Z.; Neumann, Peter

A Multistakeholder Effort to Further Real-World Evidence in Healthcare Decision Making

VALUE IN HEALTH

IF6

2023-04-01

OAAI

Pizzi, Laura T.; Willke, Richard J.

Developing Patient-Centered Real-World Evidence: Emerging Methods Recommendations From a Consensus Process 开发以患者为中心的真实世界证据: 来自共识过程的新兴方法建议

VALUE IN HEALTH

IF6

2023-01-01

OAAI

Oehrlein, Elisabeth M.; Schoch, Silke; Burcu, Mehmet; McBeth, Julia F.; Bright, Jennifer; Pashos, Chris L.; Willke, Richard; Love, T. Rosie; Mattingly II, T. Joseph; Perfetto, Eleanor M.; Patient Ctr Real World Evidence Working Grp

The History and Future of the ISPOR Value Flower: Addressing Limitations of Conventional Cost-Effectiveness Analysis

VALUE IN HEALTH

IF6

2022-04-01

OAAI

Neumann, Peter J.; Garrison, Louis P.; Willke, Richard J.

CHEERS to Updated Guidelines for Reporting Health Economic Evaluations!

VALUE IN HEALTH

IF6

2022-01-01

OAAI

Willke, Richard J.; Pizzi, Laura T.

Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials

BMC MEDICINE

IF8.3

2021-12-06

OAAI

Hong, Yoon Duk; Jansen, Jeroen P.; Guerino, John; Berger, Marc L.; Crown, William; Goettsch, Wim G.; Mullins, C. Daniel; Willke, Richard J.; Orsini, Lucinda S.

Linked Pharmacometric-Pharmacoeconomic Modeling and Simulation in Clinical Drug Development

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2020-10-26

OAAI

Hill-McManus, Daniel; Marshall, Scott; Liu, Jing; Willke, Richard J.; Hughes, Dyfrig A.

Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative 提高透明度以建立对假设检验的真实世界二次数据研究的信任-为什么，什么和如何: 来自真实世界证据透明度倡议的建议和路线图

VALUE IN HEALTH

IF6

2020-09-01

OAAI

Orsini, Lucinda S.; Berger, Marc; Crown, William; Daniel, Gregory; Eichler, Hans-Georg; Goettsch, Wim; Graff, Jennifer; Guerino, John; Jonsson, Pall; Lederer, Nirosha Mahendraratnam; Monz, Brigitta; Mullins, C. Daniel; Schneeweiss, Sebastian; Van Brunt, David; Wang, Shirley, V; Willke, Richard J.

Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report

VALUE IN HEALTH

IF6

2020-04-01

OAAI

Malone, Daniel C.; Ramsey, Scott D.; Patrick, Donald L.; Johnson, F. Reed; Mullins, C. Daniel; Roberts, Mark S.; Willke, Richard J.; Marshall, Deborah A.

Current Value Frameworks-What's New?

VALUE IN HEALTH

IF6

2019-06-01

OAAI

Willke, Richard J.; Chapman, Richard H.; Seidman, Joshua J.; Schnipper, Lowell E.; Gleason, Patrick P.

A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7]

VALUE IN HEALTH

IF6

2018-02-01

121

OAAI

Garrison, Louis P., Jr.; Neumann, Peter J.; Willke, Richard J.; Basu, Anirban; Danzon, Patricia M.; Doshi, Jalpa A.; Drummond, Michael F.; Lakdawalla, Darius N.; Pauly, Mark V.; Phelps, Charles E.; Ramsey, Scott D.; Towse, Adrian; Weinstein, Milton C.

Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6]

VALUE IN HEALTH

IF6

2018-02-01

OAAI

Willke, Richard J.; Neumann, Peter J.; Garrison, Louis P., Jr.; Ramsey, Scott D.

A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1]

VALUE IN HEALTH

IF6

2018-02-01

OAAI

Neumann, Peter J.; Willke, Richard J.; Garrison, LouisP., Jr.

An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]

VALUE IN HEALTH

IF6

2018-02-01

150

OAAI

Garrison, Louis P., Jr.; Pauly, Mark V.; Willke, Richard J.; Neumann, Peter J.

ISPOR Code of Ethics 2017 (4th Edition)

VALUE IN HEALTH

IF6

2017-12-01

OAAI

Santos, Jessica; Palumbo, Francis; Molsen-David, Elizabeth; Willke, Richard J.; Binder, Louise; Drummond, Michael; Ho, Anita; Marder, William D.; Parmenter, Louis; Sandhu, Gurmit; Shafie, Asrul A.; Thompson, David

Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making 治疗和/或比较有效性的真实世界数据研究的良好实践: ISPOR-ISPE联合特别工作组关于医疗保健决策中真实世界证据的建议

VALUE IN HEALTH

IF6

2017-09-01

188

OAAI

Berger, Marc L.; Sox, Harold; Willke, Richard J.; Brixner, Diana L.; Eichler, Hans-Georg; Goettsch, Wim; Madigan, David; Makady, Amr; Schneeweiss, Sebastian; Tarricone, Rosanna; Wang, Shirley V.; Watkins, John; Mullins, C. Daniel

Advancing High-Quality Value Assessments of Health Care Interventions INTRODUCTION

VALUE IN HEALTH

IF6

2017-02-01

OAAI

Doshi, Jalpa A.; Willke, Richard J.

Translating Pharmacometrics to a Pharmacoeconomic Model of COPD

VALUE IN HEALTH

IF6

2016-12-01

PREAI

Slejko, Julia F.; Willke, Richard J.; Ribbing, Jakob; Milligan, Peter

Comparative Effectiveness And Cost-Effectiveness Analyses Frequently Agree On Value

HEALTH AFFAIRS

IF8.1

2015-05-01

PREAI

Glick, Henry A.; McElligott, Sean; Pauly, Mark V.; Willke, Richard J.; Bergquist, Henry; Doshi, Jalpa; Fleisher, Lee A.; Kinosian, Bruce; Perfetto, Eleanor; Polsky, Daniel E.; Schwartz, J. Sanford

研究方向